.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Teva
Argus Health
McKesson
Chubb
Citi
Federal Trade Commission
Cerilliant
Boehringer Ingelheim
Dow

Generated: November 24, 2017

DrugPatentWatch Database Preview

Novast Labs Company Profile

« Back to Dashboard

What is the competitive landscape for NOVAST LABS, and what generic and branded alternatives to NOVAST LABS drugs are available?

NOVAST LABS has thirty-two approved drugs.

There are three tentative approvals on NOVAST LABS drugs.

Summary for Novast Labs

US Patents:0
Tradenames:31
Ingredients:18
NDAs:32
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novast Labs Ltd
INDOMETHACIN
indomethacin
CAPSULE, EXTENDED RELEASE;ORAL204853-001May 8, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
acetaminophen; butalbital; caffeine
TABLET;ORAL040864-001Dec 1, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
LARIN 1.5/30
ethinyl estradiol; norethindrone acetate
TABLET;ORAL-21202996-001Mar 20, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
MAFENIDE ACETATE
mafenide acetate
FOR SOLUTION;TOPICAL206716-001Jul 31, 2017ATRXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
NIFEDIPINE
nifedipine
TABLET, EXTENDED RELEASE;ORAL202987-002Aug 25, 2016AB1RXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
LEVONEST
ethinyl estradiol; levonorgestrel
TABLET;ORAL-28090719-001Dec 29, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
FALMINA
ethinyl estradiol; levonorgestrel
TABLET;ORAL-28090721-001Mar 28, 2012AB1RXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
NIFEDIPINE
nifedipine
TABLET, EXTENDED RELEASE;ORAL202987-003Aug 25, 2016AB1RXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
TRI-LINYAH
ethinyl estradiol; norgestimate
TABLET;ORAL-28090524-001May 30, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Novast Labs Ltd
ELINEST
ethinyl estradiol; norgestrel
TABLET;ORAL-28091105-001Mar 28, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Fish and Richardson
Moodys
Medtronic
QuintilesIMS
Citi
Accenture
Deloitte
Johnson and Johnson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot